Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jerry Silverman
Daclizumab Is More Effective in Reducing Relapse Rates in Multiple Sclerosis Patients Than Interferon Beta-1a
Journal of pharmacology & clinical research
Related publications
Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a
Journal of Negative Results in BioMedicine
Genetics
Pharmacology
Molecular Biology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy
Multiple Sclerosis
Neurology
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated With Interferon Beta 1a by 1h-NMR Spectroscopy
Neurotherapeutics
Neurology
Pharmacology
Treatment Recommendations for Interferon-Beta in Multiple Sclerosis
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis
Archives of Neurology
Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Relapse in Multiple Sclerosis
British Medical Journal
Medicine
The Effect of Interferon-Beta on Oxidative Stress in Patients With Multiple Sclerosis
Annals of the College of Medicine, Mosul
Glutathione in Multiple Sclerosis: More Than Just an Antioxidant?
Multiple Sclerosis
Neurology